{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "listed-father",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Getting 10 publications containing Tuberculosis...\n",
      "<class 'http.client.HTTPResponse'> type h1\n",
      "<class 'Bio.Entrez.Parser.DictionaryElement'> type result\n",
      "Total number of publications containing Tuberculosis: 267360\n",
      "<class '_io.TextIOWrapper'> type h2\n",
      "<class 'Bio.Entrez.Parser.DictionaryElement'> type records\n",
      "{'PMID': '33743471', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1879-0070 (Electronic) 0732-8893 (Linking)', 'VI': '100', 'IP': '3', 'DP': '2021 Feb 24', 'TI': 'Molecular detection of Mycobacterium tuberculosis in blood stained sputum samples using GeneXpert PCR assay.', 'PG': '115363', 'LID': 'S0732-8893(21)00056-0 [pii] 10.1016/j.diagmicrobio.2021.115363 [doi]', 'AB': \"This study investigated the possibility of detecting Mycobacterium tuberculosis (MTB) in blood-stained sputa with GeneXpert assay (Xpert MTB/Rif G4 v.5) using appropriate blood lysing (distilled water and distilled water/carbon tetrachloride) and protein denaturing (guanidinium chloride and heat) agents. Blood free sputa were collected from individuals infected with MTB. Various levels of blood-spiked sputa (0%-50%) were prepared and subsequently assayed with GeneXpert analyzer. GeneXpert was found to be reproducible at less than 2% blood contamination. However, beyond 5% blood contamination, GeneXpert was unreliable with absolute PCR inhibition at 20% of blood contamination. Boiling at 95 degrees C for 5 minutes was able to recover MTB DNA in previously undetectable levels as well as in 57% of patients' sputa with blood stains with previous negative GeneXpert results.\", 'CI': ['Copyright (c) 2021 Elsevier Inc. All rights reserved.'], 'FAU': ['Aninagyei, Enoch', 'Ayivor-Djanie, Reuben', 'Attoh, Juliana', 'Dakorah, Mavis Puopelle', 'Ginko, Muniru Nuhu', 'Acheampong, Desmond Omane'], 'AU': ['Aninagyei E', 'Ayivor-Djanie R', 'Attoh J', 'Dakorah MP', 'Ginko MN', 'Acheampong DO'], 'AD': ['Department of Biomedical Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences, Ho, Volta Region, Ghana. Electronic address: eaninagyei@uhas.edu.gh.', 'Department of Biomedical Sciences, School of Basic and Biomedical Sciences, University of Health and Allied Sciences, Ho, Volta Region, Ghana.', 'Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.', 'Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana.', 'Clinical Laboratory Unit, Ghana Health Service, Ga West Municipal Hospital, Amasaman, Accra, Ghana.', 'Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Ghana. Electronic address: dacheampong@ucc.edu.gh.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20210224', 'PL': 'United States', 'TA': 'Diagn Microbiol Infect Dis', 'JT': 'Diagnostic microbiology and infectious disease', 'JID': '8305899', 'SB': 'IM', 'OTO': ['NOTNLM'], 'OT': ['Blood spiked sputum', 'GeneXpert assay', 'Mycobacterium tuberculosis', 'blood lysing agent', 'protein denaturant'], 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 20:16'], 'PHST': ['2020/12/06 00:00 [received]', '2021/02/21 00:00 [revised]', '2021/02/22 00:00 [accepted]', '2021/03/20 20:16 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['S0732-8893(21)00056-0 [pii]', '10.1016/j.diagmicrobio.2021.115363 [doi]'], 'PST': 'aheadofprint', 'SO': 'Diagn Microbiol Infect Dis. 2021 Feb 24;100(3):115363. doi: 10.1016/j.diagmicrobio.2021.115363.'}\n",
      "{'PMID': '33743373', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1876-035X (Electronic) 1876-0341 (Linking)', 'VI': '14', 'IP': '4', 'DP': '2021 Jan 11', 'TI': 'Tuberculosis: A persistent unpleasant neighbour of humans.', 'PG': '508-513', 'LID': 'S1876-0341(21)00009-5 [pii] 10.1016/j.jiph.2021.01.005 [doi]', 'AB': \"Mycobacterium tuberculosis, the bacterium that causes tuberculosis, has long been an unpleasant neighbour of humans. Following transmission of the bacterium from patients with active infection, new hosts do not immediately develop symptoms, as M. tuberculosis initially remains quiescent. However, it is eventually triggered, leading to the infection of other individuals. Humans are the exclusive host, and the rapid proliferation of the human population worldwide along with increasing globalisation have contributed to the pathogen's persistence, as have the survival strategies employed by M. tuberculosis, especially its resistance to several antimicrobials. Defeating this enemy will require novel approaches.\", 'CI': ['Copyright (c) 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.'], 'FAU': ['Seki, Mitsuko', 'Choi, Hongjo', 'Kim, Kyungjong', 'Whang, Jake', 'Sung, Joohon', 'Mitarai, Satoshi'], 'AU': ['Seki M', 'Choi H', 'Kim K', 'Whang J', 'Sung J', 'Mitarai S'], 'AD': ['Division of Pediatric Dentistry, Department of Human Development and Fostering, Meikai University School of Dentistry, 1-1, Keyakidai, Sakado, Saitama 350-0283, Japan; Division of Microbiology, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo 173-8610, Japan. Electronic address: mitsuko.seki@dent.meikai.ac.jp.', 'Department of Preventive Medicine, College of Medicine, Konyang University, Daejeon, 35365, Republic of Korea.', 'Korea Institute of Tuberculosis, Osong, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28158, Republic of Korea.', 'Korea Institute of Tuberculosis, Osong, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do 28158, Republic of Korea.', 'Genome and Health Big Data Laboratory, Department of Public Health, Graduate School of Public Health, Seoul National University, Seoul 08826, Republic of Korea.', 'Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, 3-1-24 Matsuyama, Kiyose-shi, Tokyo 204-8533, Japan. Electronic address: mitarai@jata.or.jp.'], 'LA': ['eng'], 'PT': ['Journal Article', 'Review'], 'DEP': '20210111', 'PL': 'England', 'TA': 'J Infect Public Health', 'JT': 'Journal of infection and public health', 'JID': '101487384', 'SB': 'IM', 'OTO': ['NOTNLM'], 'OT': ['Diagnosis', 'M/XDR-TB', 'Resource-limited settings', 'Treatment', 'Tuberculosis'], 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 20:11'], 'PHST': ['2020/06/17 00:00 [received]', '2020/10/06 00:00 [revised]', '2021/01/05 00:00 [accepted]', '2021/03/20 20:11 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['S1876-0341(21)00009-5 [pii]', '10.1016/j.jiph.2021.01.005 [doi]'], 'PST': 'aheadofprint', 'SO': 'J Infect Public Health. 2021 Jan 11;14(4):508-513. doi: 10.1016/j.jiph.2021.01.005.'}\n",
      "{'PMID': '33743266', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210321', 'IS': '1872-9142 (Electronic) 0161-5890 (Linking)', 'VI': '133', 'DP': '2021 Mar 17', 'TI': 'Extracellular vesicles in the context of Mycobacterium tuberculosis infection.', 'PG': '175-181', 'LID': 'S0161-5890(21)00057-2 [pii] 10.1016/j.molimm.2021.02.010 [doi]', 'AB': 'The production of extracellular vesicles (EVs) has emerged as an important process in bacterial biology and host-pathogen interactions. Like many other bacteria, mycobacteria, including Mycobacterium tuberculosis (Mtb), the causative agent of human tuberculosis (TB), produces EVs in vitro and in vivo. These membrane-enclosed nanoparticles enable Mtb to secrete hydrophobic molecules, proteins, lipids and glycolipids in a concentrated and protected manner and engage in remote interactions with the host. The nature of the material secreted in mycobacterial EVs, the functional attributes of these vesicles and their potential as protective antigens have stimulated great interest in the mycobacterial field. Although the field of EVs in mycobacterial infections is developing, it has already uncovered a whole new dimension for Mtb-host interactions potentially relevant to TB pathogenesis. In this mini-review, we discuss the current evidence supporting an important role of mycobacterial EVs in modulating cellular immune response, the challenges and recent advances in understanding the mechanisms of vesicle biogenesis and the implications for development of new preventive and therapeutic tools against TB.', 'CI': ['Copyright (c) 2021 Elsevier Ltd. All rights reserved.'], 'FAU': ['Palacios, Ainhoa', 'Gupta, Shamba', 'Rodriguez, G Marcela', 'Prados-Rosales, Rafael'], 'AU': ['Palacios A', 'Gupta S', 'Rodriguez GM', 'Prados-Rosales R'], 'AD': ['Inflammation and Macrophage Plasticity Lab, CIC bioGUNE, Derio, 48160, Bizkaia, Spain. Electronic address: apalacios@cicbiogune.es.', 'Public Health Research Institute at New Jersey Medical School, Rutgers State University of New Jersey, Newark, 07103, NJ, USA.', 'Public Health Research Institute at New Jersey Medical School, Rutgers State University of New Jersey, Newark, 07103, NJ, USA.', 'Department of Preventive Medicine and Public Health and Microbiology, Autonoma University of Madrid, 28029, Madrid, Spain. Electronic address: rafael.prados@uam.es.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20210317', 'PL': 'England', 'TA': 'Mol Immunol', 'JT': 'Molecular immunology', 'JID': '7905289', 'SB': 'IM', 'OTO': ['NOTNLM'], 'OT': ['Cell-to-cell communication', 'Extracellular vesicles', 'Host-pathogen interactions', 'Immunomodulation', 'Mycobacterium tuberculosis'], 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 20:08'], 'PHST': ['2020/12/03 00:00 [received]', '2021/01/20 00:00 [revised]', '2021/02/08 00:00 [accepted]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]', '2021/03/20 20:08 [entrez]'], 'AID': ['S0161-5890(21)00057-2 [pii]', '10.1016/j.molimm.2021.02.010 [doi]'], 'PST': 'aheadofprint', 'SO': 'Mol Immunol. 2021 Mar 17;133:175-181. doi: 10.1016/j.molimm.2021.02.010.'}\n",
      "{'PMID': '33742695', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1365-4632 (Electronic) 0011-9059 (Linking)', 'DP': '2021 Mar 20', 'TI': 'Linear immunoglobulin A bullous dermatosis associated with disseminated tuberculosis.', 'LID': '10.1111/ijd.15526 [doi]', 'FAU': ['Letertre, Oriane', 'Anii, Veronica', 'Jullie, Marie-Laure', 'Milpied, Brigitte', 'Seneschal, Julien', 'Darrigade, Anne-Sophie'], 'AU': ['Letertre O', 'Anii V', 'Jullie ML', 'Milpied B', 'Seneschal J', 'Darrigade AS'], 'AD': ['Department of Dermatology, Hopital Saint Andre, CHU de Bordeaux, France.', \"Department of Internal Medicine, CH d'Arcachon, France.\", 'Department of Pathology, Hopital du Haut Leveque, CHU de Bordeaux, France.', 'Department of Dermatology, Hopital Saint Andre, CHU de Bordeaux, France.', 'Department of Dermatology, Hopital Saint Andre, CHU de Bordeaux, France.', 'Department of Dermatology, Hopital Saint Andre, CHU de Bordeaux, France.'], 'LA': ['eng'], 'PT': ['Letter'], 'DEP': '20210320', 'PL': 'England', 'TA': 'Int J Dermatol', 'JT': 'International journal of dermatology', 'JID': '0243704', 'SB': 'IM', 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 12:08'], 'PHST': ['2021/02/12 00:00 [revised]', '2020/10/28 00:00 [received]', '2021/02/26 00:00 [accepted]', '2021/03/20 12:08 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['10.1111/ijd.15526 [doi]'], 'PST': 'aheadofprint', 'SO': 'Int J Dermatol. 2021 Mar 20. doi: 10.1111/ijd.15526.'}\n",
      "{'PMID': '33742636', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '0300-5283 (Print) 0300-5283 (Linking)', 'VI': '76', 'IP': '2', 'DP': '2021 Mar', 'TI': 'The Cobblestone Heart.', 'PG': '241-244', 'AB': \"Sarcoidosis is a chronic, multisystem disorder. A 38 years old lady presented at Hospital Raja Perempuan Zainab II, Kota Bharu ,Malaysia with cough and breathless for 2 months and constitutional symptoms of weight loss and loss of appetite. She was initially treated as smear negative pulmonary tuberculosis for 5 months. However, her clinical condition deteriorated with worsening New York Heart Association (NYHA) class 1 to class 3. Subsequently, workout of computed tomography( CT) thorax showed multiple perilymphatic distribution of nodules and multiple mediastinal lymphadenopathy coupled with pleura biopsy showed non caseating granuloma and cardiac magnetic resonance imaging (MRI) with positive late gadolinium enhancement revised the diagnosis of pulmonary sarcoidosis with cardiac involvement. Patient's functional status and cough improved with immunosuppresant was given in tapering dose fashion.\", 'FAU': ['Tan, W J', 'Suz, C S', 'Azza, O', 'Zuki, M'], 'AU': ['Tan WJ', 'Suz CS', 'Azza O', 'Zuki M'], 'AD': ['Hospital Raja Perempuan Zainab II, Department of Medicine, Kota Bharu, Malaysia. tanwangjie@gmail.com.', 'Hospital Raja Perempuan Zainab II, Department of Medicine, Kota Bharu, Malaysia.', 'Hospital Raja Perempuan Zainab II, Department of Medicine, Kota Bharu, Malaysia.', 'Hospital Raja Perempuan Zainab II, Department of Medicine, Kota Bharu, Malaysia.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'PL': 'Malaysia', 'TA': 'Med J Malaysia', 'JT': 'The Medical journal of Malaysia', 'JID': '0361547', 'SB': 'IM', 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 12:06'], 'PHST': ['2021/03/20 12:06 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'PST': 'ppublish', 'SO': 'Med J Malaysia. 2021 Mar;76(2):241-244.'}\n",
      "{'PMID': '33742475', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1097-458X (Electronic) 0749-1581 (Linking)', 'DP': '2021 Mar 19', 'TI': 'Plain (1) H NMR Analysis Streamlines the Quality Control of Antiviral Favipiravir and Congeneric WHO Essential Medicines.', 'LID': '10.1002/mrc.5154 [doi]', 'AB': 'Favipiravir is an established antiviral currently assessed as an investigational drug for the treatment of COVID-19. Favipiravir is strikingly similar to two molecules that WHO lists as essential medicines, which also consist of a six-membered aromatic N-heterocycle bearing a carboxamide function: the anti-tuberculosis agent, pyrazinamide, and nicotinamide, aka vitamin B3 . We demonstrate the utility of (1) H NMR profiling, an emerging pharmacopoeial tool, for the highly specific identification, selective differentiation of congeners, and subsequent detection of drug falsification or adulteration of these medicines. The straightforward comparison of basic 1D (1) H NMR spectra, obtained with benchtop or advanced NMR instruments alike, offers a rapid identity assay and works independently of physical reference materials. This approach accelerates and advances pharmaceutical quality control measures under situations of increased drug demand and altered economy, such as during a pandemic.', 'CI': ['This article is protected by copyright. All rights reserved.'], 'FAU': ['Achanta, Prabhakar S', 'Chen, Shao-Nong', 'Pauli, Guido F'], 'AU': ['Achanta PS', 'Chen SN', 'Pauli GF'], 'AD': ['WHO Collaborating Center for Traditional Medicine, Program for Collaborative Research in the Pharmaceutical Sciences (PCRPS) and Pharmacognosy Institute, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'WHO Collaborating Center for Traditional Medicine, Program for Collaborative Research in the Pharmaceutical Sciences (PCRPS) and Pharmacognosy Institute, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'Institute for Tuberculosis Research (ITR), College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'WHO Collaborating Center for Traditional Medicine, Program for Collaborative Research in the Pharmaceutical Sciences (PCRPS) and Pharmacognosy Institute, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'Department of Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.', 'Institute for Tuberculosis Research (ITR), College of Pharmacy, University of Illinois at Chicago, Chicago, IL, 60612, USA.'], 'AUID': ['ORCID: https://orcid.org/0000-0003-1022-4326'], 'LA': ['eng'], 'PT': ['Letter'], 'DEP': '20210319', 'PL': 'England', 'TA': 'Magn Reson Chem', 'JT': 'Magnetic resonance in chemistry : MRC', 'JID': '9882600', 'SB': 'IM', 'OTO': ['NOTNLM'], 'OT': ['1H NMR', 'Favipiravir', 'antiviral', 'nicotinamide', 'pyrazinamide', 'quality control'], 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 06:54'], 'PHST': ['2021/03/07 00:00 [revised]', '2021/02/19 00:00 [received]', '2021/03/18 00:00 [accepted]', '2021/03/20 06:54 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['10.1002/mrc.5154 [doi]'], 'PST': 'aheadofprint', 'SO': 'Magn Reson Chem. 2021 Mar 19. doi: 10.1002/mrc.5154.'}\n",
      "{'PMID': '33742312', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1920-7476 (Electronic) 0008-4263 (Linking)', 'DP': '2021 Mar 19', 'TI': 'Tuberculosis in Canada: who counts?', 'LID': '10.17269/s41997-021-00506-7 [doi]', 'FAU': ['Heffernan, Courtney'], 'AU': ['Heffernan C'], 'AUID': ['ORCID: http://orcid.org/0000-0003-1241-7201'], 'AD': ['Tuberculosis Program Evaluation and Research Unit, Department of Medicine, University of Alberta, Room 8333A, Aberhart Centre, 11402 University Avenue, Edmonton, Alberta, T6G 2J3, Canada. cheffern@ualberta.ca.'], 'LA': ['eng'], 'PT': ['Letter'], 'DEP': '20210319', 'PL': 'Switzerland', 'TA': 'Can J Public Health', 'JT': 'Canadian journal of public health = Revue canadienne de sante publique', 'JID': '0372714', 'SB': 'IM', 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 06:47'], 'PHST': ['2021/03/02 00:00 [received]', '2021/03/09 00:00 [accepted]', '2021/03/20 06:47 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['10.17269/s41997-021-00506-7 [doi]', '10.17269/s41997-021-00506-7 [pii]'], 'PST': 'aheadofprint', 'SO': 'Can J Public Health. 2021 Mar 19. pii: 10.17269/s41997-021-00506-7. doi: 10.17269/s41997-021-00506-7.'}\n",
      "{'PMID': '33741796', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1473-6527 (Electronic) 0951-7375 (Linking)', 'DP': '2021 Mar 17', 'TI': 'Neuroradiology of infectious diseases.', 'LID': '10.1097/QCO.0000000000000725 [doi]', 'AB': 'PURPOSE OF REVIEW: Early diagnosis of central nervous system (CNS) infections is crucial given high morbidity and mortality. Neuroimaging in CNS infections is widely used to aid in the diagnosis, treatment and to assess the response to antibiotic and neurosurgical interventions. RECENT FINDINGS: The Infectious Diseases Society of America (IDSA) guidelines have clear recommendations for obtaining a computerized tomography of the head (CTH) prior to lumbar puncture (LP) in suspected meningitis. In the absence of indications for imaging or in aseptic meningitis, cranial imaging is of low utility. In contrast, cranial imaging is of utmost importance in the setting of encephalitis, bacterial meningitis, ventriculitis, bacterial brain abscess, subdural empyema, epidural abscess, neurobrucellosis, neurocysticercosis, and CNS tuberculosis that can aid clinicians with the differential diagnosis, source of infection (e.g., otitis, sinusitis), assessing complications of meningitis (e.g., hydrocephalus, venous sinus thrombosis, strokes), need for neurosurgical interventions and to monitor for the response of therapy. Novel imaging techniques such as fast imaging employing steady-state acquisition (FIESTA), susceptibility-weighted imaging (SWI), and chemical exchange saturation transfer (CEST) contrast are briefly discussed. SUMMARY: Though the radiological findings in CNS infections are vast, certain patterns along with clinical clues from history and examination often pave the way to early diagnosis. This review reiterates the importance of obtaining cranial imaging when necessary, and the various radiological presentations of commonly encountered CNS infections.', 'CI': ['Copyright (c) 2021 Wolters Kluwer Health, Inc. All rights reserved.'], 'FAU': ['Singh, Sonia Kaur', 'Hasbun, Rodrigo'], 'AU': ['Singh SK', 'Hasbun R'], 'AD': ['Department of Neurology, UT Health McGovern Medical School, Houston, Texas Section of Infectious Diseases, UT Health McGovern Medical School, Houston, Texas, USA.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20210317', 'PL': 'United States', 'TA': 'Curr Opin Infect Dis', 'JT': 'Current opinion in infectious diseases', 'JID': '8809878', 'SB': 'IM', 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 06:07'], 'PHST': ['2021/03/20 06:07 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['10.1097/QCO.0000000000000725 [doi]', '00001432-900000000-99058 [pii]'], 'PST': 'aheadofprint', 'SO': 'Curr Opin Infect Dis. 2021 Mar 17. pii: 00001432-900000000-99058. doi: 10.1097/QCO.0000000000000725.'}\n",
      "{'PMID': '33741562', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '2059-7908 (Print) 2059-7908 (Linking)', 'VI': '6', 'IP': '3', 'DP': '2021 Mar', 'TI': 'World TB day: a new opportunity to reimagine workplace health.', 'LID': 'e005601 [pii] 10.1136/bmjgh-2021-005601 [doi]', 'FAU': ['Reid, Michael', 'Silva, Sachin', 'Goosby, Eric P'], 'AU': ['Reid M', 'Silva S', 'Goosby EP'], 'AUID': ['ORCID: http://orcid.org/0000-0001-6777-9619'], 'AD': ['Medicine, UCSF, San Francisco, California, USA michael.reid@ucsf.edu.', 'T.H. Chan School of public health, Harvard University, Cambridge, Massachusetts, USA.', 'Medicine, UCSF, San Francisco, California, USA.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'PL': 'England', 'TA': 'BMJ Glob Health', 'JT': 'BMJ global health', 'JID': '101685275', 'SB': 'H IM', 'OTO': ['NOTNLM'], 'OT': ['COVID-19', 'health economics', 'tuberculosis'], 'COIS': ['Competing interests: None declared.'], 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 06:03'], 'PHST': ['2021/03/05 00:00 [received]', '2021/03/07 00:00 [accepted]', '2021/03/20 06:03 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['bmjgh-2021-005601 [pii]', '10.1136/bmjgh-2021-005601 [doi]'], 'PST': 'ppublish', 'SO': 'BMJ Glob Health. 2021 Mar;6(3). pii: bmjgh-2021-005601. doi: 10.1136/bmjgh-2021-005601.'}\n",
      "{'PMID': '33741489', 'OWN': 'NLM', 'STAT': 'Publisher', 'LR': '20210320', 'IS': '1878-3511 (Electronic) 1201-9712 (Linking)', 'DP': '2021 Mar 16', 'TI': 'Whole genome sequencing based differentiation between re-infection and relapse in Indian patients with tuberculosis recurrence, with and without HIV co-infection.', 'LID': 'S1201-9712(21)00238-1 [pii] 10.1016/j.ijid.2021.03.020 [doi]', 'AB': 'INTRODUCTION: Differentiation between relapse and reinfection in cases with tuberculosis (TB) recurrence has important implications for public health, especially in patients with human immunodeficiency virus (HIV) co-infection. We compared Mycobacterial Interspersed Repeat Unit (MIRU) typing and spoligotyping with whole genome sequencing (WGS) to differentiate between relapse and reinfection in patients (HIV-positive and HIV-negative) with TB recurrence. We also assessed the value of WGS to track acquired drug resistance in those with relapse after successful treatment. METHOD: Forty-one paired M. tuberculosis isolates collected from 20 HIV-positive and 21 HIV-negative patients were subjected to WGS in addition to spoligotyping and MIRU typing. Phylogenetic and Single Nucleotide Substitution (SNP) clustering analyses were performed to determine whether recurrences were due to relapse or re-infection. RESULTS: Comparison of M. tuberculosis genomes indicated that 95% of TB recurrences in the HIV-negative cohort were due to relapse, while the majority of TB recurrences (75%) in the HIV-positive cohort was due to reinfection (P = 0.0001). New drug resistance mutations were acquired in 5/24 cases (20.8%) that experienced relapse. CONCLUSIONS: WGS provided increased resolution, but differentiation between relapse and reinfection was broadly consistent with MIRU and spoligotyping. The high contribution of reinfection among HIV infected patients experiencing TB recurrence warrants further study to explore risk factors for TB exposure.', 'CI': ['Copyright (c) 2021. Published by Elsevier Ltd.'], 'FAU': ['Shanmugam, Sivakumar', 'Bachmann, Nathan L', 'Martinez, Elena', 'Menon, Ranjeeta', 'Narendran, G', 'Narayanan, Sujantha', 'Tripathy, Srikanth', 'Devi, K R Uma', 'Sawleshwarkar, Shailendra', 'Marais, Ben', 'Sintchenko, Vitali'], 'AU': ['Shanmugam S', 'Bachmann NL', 'Martinez E', 'Menon R', 'Narendran G', 'Narayanan S', 'Tripathy S', 'Devi KRU', 'Sawleshwarkar S', 'Marais B', 'Sintchenko V'], 'AD': ['National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.', 'Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Sydney, New South Wales, Australia; National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India. Electronic address: nathan.bachmann@sydney.edu.au.', 'Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Sydney, New South Wales, Australia; National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.', 'Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Sydney, New South Wales, Australia; National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India; Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, New South Wales, Australia.', 'National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.', 'National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.', 'National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.', 'National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.', 'Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, New South Wales, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.', 'Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, New South Wales, Australia.', 'Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Sydney, New South Wales, Australia; National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India; Marie Bashir Institute for Infectious Diseases and Biosecurity, University of Sydney, New South Wales, Australia; Sydney Medical School, Faculty of Medicine and Health, University of Sydney, New South Wales, Australia.'], 'LA': ['eng'], 'PT': ['Journal Article'], 'DEP': '20210316', 'PL': 'Canada', 'TA': 'Int J Infect Dis', 'JT': 'International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases', 'JID': '9610933', 'SB': 'IM', 'OTO': ['NOTNLM'], 'OT': ['Antimicrobial resistance', 'HIV', 'Mycobacterium tuberculosis', 'Single nucleotide polymorphism', 'co-infection', 'genome sequencing', 'recurrence'], 'EDAT': '2021/03/21 06:00', 'MHDA': '2021/03/21 06:00', 'CRDT': ['2021/03/20 06:01'], 'PHST': ['2020/11/10 00:00 [received]', '2021/03/09 00:00 [revised]', '2021/03/09 00:00 [accepted]', '2021/03/20 06:01 [entrez]', '2021/03/21 06:00 [pubmed]', '2021/03/21 06:00 [medline]'], 'AID': ['S1201-9712(21)00238-1 [pii]', '10.1016/j.ijid.2021.03.020 [doi]'], 'PST': 'aheadofprint', 'SO': 'Int J Infect Dis. 2021 Mar 16. pii: S1201-9712(21)00238-1. doi: 10.1016/j.ijid.2021.03.020.'}\n",
      "Authors: Achanta PS, Acheampong DO, Anii V, Aninagyei E, Attoh J, Ayivor-Djanie R, Azza O, Bachmann NL, Chen SN, Choi H, Dakorah MP, Darrigade AS, Devi KRU, Ginko MN, Goosby EP, Gupta S, Hasbun R, Heffernan C, Jullie ML, Kim K, Letertre O, Marais B, Martinez E, Menon R, Milpied B, Mitarai S, Narayanan S, Narendran G, Palacios A, Pauli GF, Prados-Rosales R, Reid M, Rodriguez GM, Sawleshwarkar S, Seki M, Seneschal J, Shanmugam S, Silva S, Singh SK, Sintchenko V, Sung J, Suz CS, Tan WJ, Tripathy S, Whang J, Zuki M\n"
     ]
    }
   ],
   "source": [
    "from Bio import Entrez\n",
    "from Bio import Medline\n",
    "\n",
    "MAX_COUNT = 10\n",
    "li = []\n",
    "TERM = 'Tuberculosis'\n",
    "\n",
    "print('Getting {0} publications containing {1}...'.format(MAX_COUNT, TERM))\n",
    "Entrez.email = 'A.N.Other@example.com'\n",
    "h = Entrez.esearch(db='pubmed', retmax=MAX_COUNT, term=TERM)\n",
    "print(type(h),\"type h1\")\n",
    "result = Entrez.read(h)\n",
    "print(type(result),\"type result\")\n",
    "print('Total number of publications containing {0}: {1}'.format(TERM, result['Count']))\n",
    "ids = result['IdList']\n",
    "h = Entrez.efetch(db='pubmed', id=ids, rettype='medline', retmode='text')\n",
    "print(type(h),\"type h2\")\n",
    "records = Medline.parse(h)\n",
    "print(type(result),\"type records\")\n",
    "\n",
    "\n",
    "authors = []\n",
    "for record in records:\n",
    "    print(record)\n",
    "    au = record.get('AU', '?')\n",
    "    for a in au: \n",
    "        if a not in authors:\n",
    "            authors.append(a)\n",
    "    authors.sort()\n",
    "print('Authors: {0}'.format(', '.join(authors)))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "sized-meaning",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.5"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
